OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy
Cyprine Neba Funeh, Jessica Bridoux, Thomas Ertveldt, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1378-1378
Open Access | Times Cited: 10

Showing 10 citing articles:

Expanding Role for Gallium-68 PET Imaging in Oncology
Janke Kleynhans, Thomas Ebenhan, Mike Sathekge
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 6, pp. 778-791
Closed Access | Times Cited: 5

Revolutionizing cancer treatment: The role of radiopharmaceuticals in modern cancer therapy
Treesa P. Varghese, Anish John, Jithin Mathew
Precision Radiation Oncology (2024)
Open Access | Times Cited: 4

Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy?
Janke Kleynhans, Thomas Ebenhan, Frederik Cleeren, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 7, pp. 1965-1980
Open Access | Times Cited: 3

Efficient α and β− radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model
Hannelore Ceuppens, Ana Rita Pombo Antunes, Laurent Navarro, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Closed Access | Times Cited: 3

Targeting Cancer Stem Cells with Radioimmunotherapy: The Case of the Ovarian Cancer Stemness-Associated Biomarker L1CAM
Tihomir Zh. Todorov, Roger Schibli, Martin Béhé, et al.
International Journal of Translational Medicine (2024) Vol. 4, Iss. 3, pp. 463-485
Open Access | Times Cited: 2

Preclinical Evaluation of226Ac as a Theranostic Agent: Imaging, Dosimetry, and Therapy
Helena Koniar, Luke Wharton, Aidan Ingham, et al.
Journal of Nuclear Medicine (2024), pp. jnumed.124.267999-jnumed.124.267999
Closed Access | Times Cited: 2

Radionuclide-labelled nanoparticles for cancer combination therapy: a review
Na Sun, Tao Wang, Song Zhang
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2

Advancements in Nuclear Imaging Using radiolabeled Nanobody tracers to support Cancer Immunotherapy
Katty Zeven, Yoline Lauwers, Lynn De Mey, et al.
Immunotherapy Advances (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 1

Hydroxyapatite Nanocrystals Integrated into Mesoporous Silica for Sustained Delivery of Doxorubicin
Isabela A. A. Bessa, João Victor Roza Cruz, Aline Farias Moreira Da Silva, et al.
ACS Applied Nano Materials (2023) Vol. 7, Iss. 16, pp. 18450-18466
Closed Access | Times Cited: 3

An Overview of Structural Framework and Classification of Theranostic Radiopharmaceuticals
Jasleen Kaur, Monalisa Mukherjee
ChemistrySelect (2024) Vol. 9, Iss. 38
Closed Access

Page 1

Scroll to top